Jain Nikunj 4

What Happened
Jain Nikunj, Principal Accounting Officer at Sangamo Therapeutics (SGMO), surrendered a total of 5,785 shares of company stock to satisfy mandatory tax withholding tied to RSU vestings. On Feb 24, 2026 he surrendered 666 shares at the closing price of $0.4725 (proceeds reported as $315) and on Feb 25, 2026 he surrendered 5,119 shares at $0.47 ($2,406). These transactions are tax-withholding dispositions (transaction code F) to the issuer and are not open-market sales.

Key Details

• Transaction dates and prices: Feb 24, 2026 — 666 shares @ $0.4725 (reported $315); Feb 25, 2026 — 5,119 shares @ $0.47 (reported $2,406).
• Total surrendered: 5,785 shares for a combined $2,721.
• Shares owned after transaction: Not disclosed in the provided filing excerpt.
• Footnotes: The shares surrendered were the portion of RSU grants that vested on Feb 24 and Feb 25, 2026 and were withheld solely to satisfy mandatory tax withholding under the company’s 2018 Equity Incentive Plan (see F1–F4). These are deemed dispositions for reporting but do not represent discretionary open-market trades.
• Filing timeliness: Report filed Feb 26, 2026 for transactions on Feb 24–25, 2026 (timely).

Context
Tax-withholding share surrenders are routine administrative transactions when RSUs vest and do not necessarily signal insider buying or selling intent. The amounts here are small (~$2.7k total) and reflect withholding rather than a discretionary liquidation. Transaction code F denotes withholding of shares to cover tax obligations.